The Flare
Home
Briefings
Shop
Search
Subscribe
background

May 5, 2026

Lupus Treatment 2026: Saphnelo SC Approval, CAR-T, & New Pipeline Drugs

Explore the May 2026 lupus landscape, featuring the newly approved Saphnelo Pen (anifrolumab SC), Gazyva (obinutuzumab) success, and the latest in CAR-T cell therapy for SLE.

The Autoimmune Crisis: An Invisible Epidemic

With 15 million Americans diagnosed and a 4.5-year average delay in treatment, the "diagnostic odyssey" is a national health crisis. We audit the clinical data and the structural gaps leaving patients underserved.


Autoimmune Disease

+6

Lupus Treatment 2026: Saphnelo SC Approval, CAR-T, & New Pipeline Drugs

May 5, 2026

•

7 min read

Lupus Treatment 2026: Saphnelo SC Approval, CAR-T, & New Pipeline Drugs

Explore the May 2026 lupus landscape, featuring the newly approved Saphnelo Pen (anifrolumab SC), Gazyva (obinutuzumab) success, and the latest in CAR-T cell therapy for SLE.

Autoimmune Disease

+8

Trauma Has an Autoimmune Risk Score

Apr 22, 2026

•

5 min read

Trauma Has an Autoimmune Risk Score

The label of being anxious or stressed delays diagnoses by years.

Autoimmune Disease

+9

May: A Preview of What's Coming

Apr 16, 2026

•

4 min read

May: A Preview of What's Coming

Lupus. Celiac. Arthritis. Myositis. IBD. Behçet's. May is about to bring lots of awareness.

Autoimmune Disease

+6

April: Hashimoto's Thyroiditis Awareness Month

Apr 14, 2026

•

5 min read

April: Hashimoto's Thyroiditis Awareness Month

For the first time, the world is viewing Hashimoto's as an immune disease, not just a "hormone disease."

Autoimmune Disease

+7

Neurological Sjögren's: The Symptoms No One Told You About

Apr 9, 2026

•

5 min read

Neurological Sjögren's: The Symptoms No One Told You About

The first-ever clinical guidelines for neurological Sjögren's were just published. Here is what they say.

Autoimmune Disease

+4

April: Sjögren's Syndrome Awareness Month

Apr 6, 2026

•

8 min read

April: Sjögren's Syndrome Awareness Month

The First Disease-Modifying Drugs for Sjögren's Are at the FDA's Door.


background

Access the briefings
Source-first clinical intelligence.
Bridging the autoimmune research gap.


Contact The Flare

For partnership inquiries, trial data reports, or feedback on our investigative briefings, please reach out via the form below.


The Flare

Independent investigative briefings on the autoimmune sector. We audit clinical trial data, drug pipelines (Sjögren’s, Lupus, Celiac, Arthritis), and the 4.5-year diagnosis gap.

© 2026 The Flare.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv